Stock listing

Pharmadrug, Inc.

Selected listing: PHRX · CSE · CAD · CA

Pharmadrug, Inc. (CSE:PHRX), Health Technology. Latest release Jan 5, 2026: PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc.…

PHRX:CSECADCAUpdated September 25, 2026

Ticker: CSE:PHRX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: CSE
Currency: CAD

About Pharmadrug, Inc.

Pharmadrug, Inc. is a public company traded under the ticker PHRX on the Canadian market. Pharmadrug focuses on developing and providing innovative solutions in the pharmaceutical sector.

Latest news from Pharmadrug, Inc.

PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

January 5, 2026

PharmaDrug Announces Debt Restructuring

October 31, 2025

PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc

October 30, 2025

PharmaDrug Inc.: Correction to News Release Dated July 30, 2025

July 30, 2025

PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.

July 30, 2025

All Pharmadrug, Inc. news →

Research Pharmadrug, Inc.

Pharmadrug, Inc. company profile

View the public company page for Pharmadrug, Inc. on 6ix.

Pharmadrug, Inc. news

Read company news and market updates connected to Pharmadrug, Inc..

Pharmadrug, Inc. investor events

Find investor webinars, events, and replay context for Pharmadrug, Inc..